6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide has been researched along with muscimol in 1 studies
| Studies (6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide) | Trials (6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide) | Recent Studies (post-2010) (6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide) | Studies (muscimol) | Trials (muscimol) | Recent Studies (post-2010) (muscimol) |
|---|---|---|---|---|---|
| 25 | 0 | 0 | 4,699 | 9 | 887 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloch, R; Bousquet, P; Feldman, J; Schwartz, J | 1 |
1 other study(ies) available for 6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide and muscimol
| Article | Year |
|---|---|
TAG antagonises the central cardiovascular effects of taurine.
Topics: Animals; Benzothiadiazines; Blood Pressure; Brain; Cats; Dose-Response Relationship, Drug; Heart Rate; Muscimol; Taurine | 1984 |